Effect of Growth Hormone Therapy on a 4-Year-Old Girl with Pfeiffer Syndrome and Short Stature: A Case Report

Fibroblast growth factor receptors (<i>FGFR</i>s) are expressed in epiphyseal cartilage cells of developing bones and regulate endochondral bone formation with interdependent signaling pathways. Gene mutation in <i>FGFR</i>s disrupts the formation of endochondral bony structu...

Full description

Bibliographic Details
Main Authors: Min Jeong Jang, Moon Bae Ahn
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Children
Subjects:
Online Access:https://www.mdpi.com/2227-9067/9/4/547
Description
Summary:Fibroblast growth factor receptors (<i>FGFR</i>s) are expressed in epiphyseal cartilage cells of developing bones and regulate endochondral bone formation with interdependent signaling pathways. Gene mutation in <i>FGFR</i>s disrupts the formation of endochondral bony structure by reducing the number of proliferating chondrocytes. Among the syndromes caused by mutation in the <i>FGFR</i> gene, Pfeiffer syndrome is a rare inherited disease characterized by acrocephalosyndactyly related to hypertelorism, broad pollex, and hallux. We describe the case of a 4-year-old girl with short stature, advanced bone age, wide thumbs and great toes. The patient was diagnosed with partial growth hormone deficiency and an identified mutation in the <i>FGFR2</i> gene. Standard deviation score of her height increased after starting growth hormone therapy. This report will raise awareness of the growth hormone provocation test regardless of bone age in patients with short stature founded <i>FGFR</i> gene mutation.
ISSN:2227-9067